NUMB

Last update 08 May 2025

Basic Info

Synonyms

C14orf41, h-Numb, NUMB

+ [3]

Introduction

Regulates clathrin-mediated receptor endocytosis (PubMed:18657069). Plays a role in the process of neurogenesis (By similarity). Required throughout embryonic neurogenesis to maintain neural progenitor cells, also called radial glial cells (RGCs), by allowing their daughter cells to choose progenitor over neuronal cell fate (By similarity). Not required for the proliferation of neural progenitor cells before the onset of neurogenesis. Also involved postnatally in the subventricular zone (SVZ) neurogenesis by regulating SVZ neuroblasts survival and ependymal wall integrity (By similarity). May also mediate local repair of brain ventricular wall damage (By similarity).

100 Clinical Results associated with NUMB

100 Translational Medicine associated with NUMB

0 Patents (Medical) associated with NUMB

912

Literatures (Medical) associated with NUMB

01 May 2025·iScience

A central role for Numb/Nbl in multiple Shh-mediated axon repulsion processes

Article

Author: Ferent, Julien ; Charron, Frederic ; Dolique, Tiphaine ; Baudet, Sarah

Sonic hedgehog (Shh) is an axon guidance molecule that can act as either a chemorepellent or a chemoattractant, depending on the neuron type and their developmental stage. In the developing spinal cord, Shh initially attracts commissural axons to the floor plate and later repels them after they cross the midline. In the developing visual system, Shh repels ipsilateral retinal ganglion cell (iRGC) axons at the optic chiasm. Although Shh requires the endocytic adaptor Numb for attraction of spinal commissural axons, the molecular mechanisms underlying Shh dual function in attraction and repulsion are still unclear. In this study, we show that Numb is essential for two Shh-mediated repulsion processes: iRGC axon repulsion at the optic chiasm and antero-posterior commissural axon repulsion in the spinal cord. Therefore, Numb is required for Shh-mediated attraction and repulsion. These results position Numb as a central player in the non-canonical Shh signaling pathway mediating axon repulsion.

01 Apr 2025·iScience

Mechanical control of the alternative splicing factor PTBP1 regulates extracellular matrix stiffness induced proliferation and cell spreading

Article

Author: Alaklobie, Mubarak ; Sun, Weiwei ; Gad, Annica K B ; Tseng, Pei-Li ; Collins, Mark O ; Erdmann, Kai S ; Salem, Ahmed ; Macfarlane, Sarah C

Cells sense mechanical cues and convert them into biochemical responses to regulate biological processes such as embryonic development, aging, cellular homeostasis, and disease progression. In this study, we introduce a large-scale, systematic approach to identify proteins with mechanosensitive nuclear localization, highlighting their potential roles in mechanotransduction. Among the proteins identified, we focus here on the splicing factor PTBP1. We demonstrate that its nuclear abundance is regulated by mechanical cues such as cell density, size, and extracellular matrix (ECM) stiffness and that PTBP1 medicates the mechanosensitive alternative splicing of the endocytic adapter protein Numb. Furthermore, we show that PTBP1 and Numb alternative splicing is critical for ECM stiffness-induced epithelial cell spreading and proliferation as well as for mesenchymal stem cell differentiation into osteoblasts on a stiff matrix. Our results underscore the emerging role of alternative splicing in mechanotransduction and provide novel mechanistic insights into how matrix stiffness modulates cellular mechanoresponses.

01 Mar 2025·International Journal of Gynecology & Obstetrics

Maternal serum Numb in the first trimester of pregnancy as a biomarker for early prediction of pre‐eclampsia: A prospective cohort study

Article

Author: Huang, Chaolin ; Jiang, Ying ; Cheng, Xuehua ; Chen, Xiaofeng ; Li, Shaoxing

AbstractObjectiveEarly identification of women at risk of developing pre‐eclampsia is beneficial as it allows for timely intervention strategies. This study aimed to evaluate the potential of serum Numb in the first trimester as a biomarker for early prediction of pre‐eclampsia.MethodsThis prospective observational cohort study was carried out at a tertiary teaching hospital between January 2021 and December 2022. A total of 1024 women were recruited during their 8–13 weeks of pregnancy and were followed up until delivery. Serum Numb levels were measured during 8–13 weeks of gestation for all participants. At the same time, the participants' anthropometric, clinical, and laboratory data were collected. A logistic regression model was used to investigate the potential association between serum Numb levels and the risk of pre‐eclampsia. Receiver operating characteristic curves (ROCs) and area under the curves (AUCs) were utilized to evaluate the predictive efficacy of serum Numb levels for pre‐eclampsia in the first trimester.ResultsSerum Numb levels were found to be significantly higher in pregnant women who developed pre‐eclampsia compared to those who did not develop pre‐eclampsia. Increased serum Numb levels were identified as an independent risk factor for pre‐eclampsia, with an odds ratio (OR) of 3.27 (95% CI: 2.05–4.53) for the risk of pre‐eclampsia. Numb levels showed a significant positive correlation with the risk of pre‐eclampsia. Furthermore, Numb levels demonstrated a strong predictive efficacy for pre‐eclampsia in the first trimester of pregnancy, with an AUC value of 0.86, a cutoff value of 48.73 ng/mL, a sensitivity of 79.24%, and a specificity of 75.73%.ConclusionSerum Numb in the first trimester of pregnancy can serve as a biomarker for the early prediction of pre‐eclampsia. This provides a valuable approach in clinical practice to identify pregnant women in the first trimester of pregnancy, who are at a higher risk of developing pre‐eclampsia.

Analysis

Perform a panoramic analysis of this field.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

NUMB

Basic Info

Related

Analysis